Skip to content

Effect of Dhatturadi Taila and Vipadikahar Ghrita Taila in Vipadika.

A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Dhatturadi Taila as compared to the efficacy of Vipadikahar Ghrita Taila in Vipadika.

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098374
Enrollment
60
Registered
2025-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L408- Other psoriasis

Interventions

None listed

Sponsors

All India Institute of Ayurveda Dhargal Goa
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Clinically diagnosed patients with Vipadika as per WHO TM2 SN9Y. 2)Patients of the 18 to 60 years of age group of any Gender, Religion, socio-economic status, or Geographical area. 3)Mild to Moderate cases of Vipadika having any 2 cardinal symptoms of Vipadika ie Panipadasphutanam, manda kandu, tivra Vedana, rukshata 4)Patients with m-PPPASI less than or equal to 50 5)Patients with DLQI less than or equal to 21 6)Patients with NRS less than or equal to 7 7)Participants who have discontinued allopathic treatment at least two weeks before. (Washout Period More than or Equal to 2 weeks) 8)Symptoms for at least 3 months 9)Able to comply with all study procedures for the duration of the study.

Exclusion criteria

Exclusion criteria: 1)Patients already diagnosed with Uncontrolled Diabetes 2)Children, Pregnant and Lactating Women 3)Immunocompromised patients (e.g. HIV infection, Hepatitis) 4)Patients having other associated skin disorders 5)Patients who have sensitivity reactions to the medicated oils 6)Vipadika skin disease with secondary infections

Design outcomes

Primary

MeasureTime frame
Improvement in signs and symptoms of Vipadika using Dhatturadi Taila and Vipadikahar Ghrita Taila. Assessed through modified Palmoplantar psoriasis area severity index score, numerical rating scale, dermatological life quality index.Timepoint: 0 week 2 week 4 week

Secondary

MeasureTime frame
Changes in the m-PPPASI scoresTimepoint: 0 week 2 week 4 week;Changes in the Dermatological Life Quality IndexTimepoint: 0 week & 4 week;Changes in NRSTimepoint: o week 2 week & 4 week;Changes in Subjective & Objective ParametersTimepoint: 0 week 2 week & 4 week;History of potential Dooshivisha Exposure in cases of VipadikaTimepoint: 0 week

Countries

India

Contacts

Public ContactADITYA YUVRAJ HATWAR

All India Institute of Ayurveda, Goa

nggramo@gmail.com9423272806

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026